By API User
12 February 2026 – Sydney, Australia | BlinkLab Limited (ASX:BB1), a leader in AI-powered digital diagnostics, has expanded its U.S. clinical footprint with the onboarding of Drexel University as the ninth site in its pivotal FDA 510(k) trial for BlinkLab Dx 1, the Company’s Software as a Medical Device (SaMD) autism diagnostic aid. The addition of … Continued
By API User
People who are benefiting from bioelectronics will be discussing their lived experience at the Australasian Bioelectronics, Neurosensing and Neuromodulation Symposium on Monday February 16. Four patients who have neurosensing/neurostimulation implants will be part of a panel – along with neurologist Professor Mark Cook – at the event at UNSW Sydney. One of the implants is … Continued
By API User
Key Facts: Research from UNSW Sydney is changing the future of precision care for genetic and rare diseases, using children’s own cells to build small organ models to test cystic fibrosis medicines on. When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to imagine what … Continued
By API User
Cleo Diagnostics Marks Ovarian Cancer Awareness Month, Reinforcing its Commitment to Earlier Detection Cleo Diagnostics (ASX: COV) is recognising Ovarian Cancer Awareness Month this February, highlighting the urgent and unmet clinical need for earlier and more accurate detection of ovarian cancer. Ovarian cancer remains one of the most challenging cancers to diagnose early, with symptoms … Continued
By API User
OncoSil Medical CEO Nigel Lange available for expert commentary on locally advanced pancreatic cancer, treatment innovation and the need for earlier detection Ahead of World Cancer Day this Wednesday February 4, Australian medical device company OncoSil Medical Ltd (ASX: OSL) is calling for greater awareness and urgency around pancreatic cancer, a disease that is often diagnosed … Continued
By API User
REYKJAVIK, Iceland, Feb. 02, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has entered into supply and commercialization agreements with Sandoz covering multiple biosimilar candidates in Canada, and in Australia and New Zealand. “These agreements with … Continued
By API User
Patients across Southeast Asia, Africa, and the United States will be among the first in the world to trial a new Australian-developed treatment for a devastating reaction to leprosy, offering the potential for life-changing care without the severe side effects of existing therapies. Announced on World Neglected Tropical Disease Day, the trial involving … Continued
By API User
Australian company OmnigeniQ has revealed the first computer model of a human protein as it exists in the body, confirming that native protein topology can be calculated directly from physics. The breakthrough was achieved using the company’s physics-based Deterministic Intelligence model that shows proteins in their native, hydrated, dynamic form – something existing tools cannot do. … Continued
By API User
Sydney, Australia – 12 January 2026: OncoSil Medical Limited (ASX: OSL) (“OncoSil Medical” or “the Company”), a medical device company focused on localised treatments for patients with unresectable locally advanced pancreatic cancer (LAPC), is pleased to announce the publication of a peer-reviewed study in Gastrointestinal Endoscopy titled: “Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone … Continued
By API User
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s lead asset PRO CAR – 201A, … Continued
